Aino Health AB (FRA:50V) 5-Year EBITDA Growth Rate: 48.50% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:50V Aino Health AB FRA:50V
24 GF Score
Price €0.03
! 5 Warning Signs
View Full Analysis

What is Aino Health AB 5-Year EBITDA Growth Rate?

Aino Health AB FRA:50V +6,100.00% 24 5-Year EBITDA Growth Rate is 48.50% as of Jun. 2026. GuruFocus rates FRA:50V with a GF Score™ of 24/100. The stock has 5 warning signs investors should review.

Aino Health AB's EBITDA per Share for the three months ended in Jun. 2026 was €-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 57.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 48.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Aino Health AB was 57.50% per year. The lowest was -302.60% per year. And the median was 37.05% per year.

Aino Health AB  (FRA:50V) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Aino Health AB 5-Year EBITDA Growth Rate Related Terms

FRA:50V vs VEEV, BTSG, TEM: 5-Year EBITDA Growth Rate Comparison

For the Health Information Services subindustry, Aino Health AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aino Health AB 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aino Health AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Aino Health AB's 5-Year EBITDA Growth Rate falls into.


FRA:50V
24GF Score
Aino Health AB FRA:50V
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aino Health AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 48.50% mean?
Aino Health AB (FRA:50V) has a 5-Year EBITDA Growth Rate of 48.50% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Aino Health AB and its competitors.
Is Aino Health AB's 5-Year EBITDA Growth Rate too high?
Aino Health AB's current 5-Year EBITDA Growth Rate is 48.50%. Overall, Aino Health AB has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Aino Health AB's 5-Year EBITDA Growth Rate compare to VEEV and BTSG?
Aino Health AB's 5-Year EBITDA Growth Rate of 48.50% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Aino Health AB and its competitors. Aino Health AB's current 5-Year EBITDA Growth Rate is 48.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aino Health AB stock overvalued right now?
Aino Health AB (FRA:50V) has a current 5-Year EBITDA Growth Rate of 48.50%. The current 5-Year EBITDA Growth Rate is 48.50%. Aino Health AB's overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Aino Health AB (FRA:50V), the current 5-Year EBITDA Growth Rate is 48.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aino Health AB Business Description

Other Exchanges AINO:Sweden
Address c/o Hermelin & Friends, Kungsgatan 32, Stockholm, SWE, 111 35
Aino Health AB provides corporate health management solutions. The company has developed a complete system of IT-based services with a focus on improving corporate health and reducing sickness absence levels in private and public organizations. Its solution consists of HealthManager, HealthDesk, and Consulting services. Company SaaS platform combines advance data analytics, research-based insights, and AI to empower leaders to unlock the full potential of their teams and to foster a healthier, more sustainable work environment.
24GF Score

Get the complete analysis for FRA:50V

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price